Suresh A - Search Results

1

Assessing the behavior management problems during the first dental visit of preschool children using a doll placement test.

Suresh A, Karuna YM, Natarajan S, Maimoona TM, Shenoy S, Nayak AP, Rao AP, Shrikrishna SB. Suresh A, et al. J Indian Soc Pedod Prev Dent. 2020 Jan-Mar;38(1):41-47. doi: 10.4103/JISPPD.JISPPD_206_19. J Indian Soc Pedod Prev Dent. 2020. PMID: 32174628

2

Molecular modeling piloted analysis for semicarbazone derivative of curcumin as a potent Abl-kinase inhibitor targeting colon cancer.

Rodrigues FC, Hari G, Pai KSR, Suresh A, Nayak UY, Anilkumar NV, Thakur G. Rodrigues FC, et al. Among authors: suresh a. 3 Biotech. 2021 Dec;11(12):506. doi: 10.1007/s13205-021-03051-9. Epub 2021 Nov 22. 3 Biotech. 2021. PMID: 34840927 Free PMC article.

3

Recent advances in the development of asenapine formulations.

Suresh A, Narayan R, Nayak UY. Suresh A, et al. Expert Opin Drug Deliv. 2020 Oct;17(10):1377-1393. doi: 10.1080/17425247.2020.1792439. Epub 2020 Jul 16. Expert Opin Drug Deliv. 2020. PMID: 32633149 Review.

4

Targeting SARS-CoV-2 RNA-dependent RNA polymerase: An in silico drug repurposing for COVID-19.

Baby K, Maity S, Mehta CH, Suresh A, Nayak UY, Nayak Y. Baby K, et al. Among authors: suresh a. F1000Res. 2020 Sep 23;9:1166. doi: 10.12688/f1000research.26359.1. eCollection 2020. F1000Res. 2020. PMID: 33204411 Free PMC article.

5

Targeting SARS-CoV-2 Main Protease: A Computational Drug Repurposing Study.

Baby K, Maity S, Mehta CH, Suresh A, Nayak UY, Nayak Y. Baby K, et al. Among authors: suresh a. Arch Med Res. 2021 Jan;52(1):38-47. doi: 10.1016/j.arcmed.2020.09.013. Epub 2020 Sep 17. Arch Med Res. 2021. PMID: 32962867 Free PMC article.

6

Advances and challenges in nintedanib drug delivery.

Velagacherla V, Suresh A, Mehta CH, Nayak UY. Velagacherla V, et al. Among authors: suresh a. Expert Opin Drug Deliv. 2021 Nov;18(11):1687-1706. doi: 10.1080/17425247.2021.1985460. Epub 2021 Oct 6. Expert Opin Drug Deliv. 2021. PMID: 34556001 Review.

7

Controlled Release Technologies for Chronotherapy: Current Status and Future Perspectives.

Bhat BB, Mehta CH, Suresh A, Velagacherla V, Nayak UY. Bhat BB, et al. Among authors: suresh a. Curr Pharm Des. 2023;29(14):1069-1091. doi: 10.2174/1381612829666230423144232. Curr Pharm Des. 2023. PMID: 37143271

8

Multi-Targeting Approach in Selection of Potential Molecule for COVID-19 Treatment.

Velagacherla V, Suresh A, Mehta CH, Nayak UY, Nayak Y. Velagacherla V, et al. Among authors: suresh a. Viruses. 2023 Jan 12;15(1):213. doi: 10.3390/v15010213. Viruses. 2023. PMID: 36680253 Free PMC article.

9

Chitosan-glucuronic acid conjugate coated mesoporous silica nanoparticles: A smart pH-responsive and receptor-targeted system for colorectal cancer therapy.

Narayan R, Gadag S, Cheruku SP, Raichur AM, Day CM, Garg S, Manandhar S, Pai KSR, Suresh A, Mehta CH, Nayak Y, Kumar N, Nayak UY. Narayan R, et al. Among authors: suresh a. Carbohydr Polym. 2021 Jun 1;261:117893. doi: 10.1016/j.carbpol.2021.117893. Epub 2021 Mar 3. Carbohydr Polym. 2021. PMID: 33766378

10

SARS-CoV-2 entry inhibitors by dual targeting TMPRSS2 and ACE2: An in silico drug repurposing study.

Baby K, Maity S, Mehta CH, Suresh A, Nayak UY, Nayak Y. Baby K, et al. Among authors: suresh a. Eur J Pharmacol. 2021 Apr 5;896:173922. doi: 10.1016/j.ejphar.2021.173922. Epub 2021 Feb 2. Eur J Pharmacol. 2021. PMID: 33539819 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

484 results

Search Page